Stibbe assisted the shareholder of ORA in relation to the sale of the company to IBA
Matter
BE Law
Expertise
Stibbe successfully assisted the shareholder of ORA (Optimized Radiochemical Applications), a global innovator in radiochemistry solutions headquartered in Belgium, in relation to the sale of the company to IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and a key player in nuclear medicine.
Image
The transaction enables ORA to partner with IBA and accelerate its growth in the fast-evolving field of nuclear medicine. By combining ORA’s innovative NEPTIS® technology with IBA’s global footprint and expertise, the collaboration creates one of the most competitive integrated solutions available to hospitals and radiopharmacy networks worldwide.
